跳至主要内容
临床试验/CTRI/2017/01/007737
CTRI/2017/01/007737招募中4 期

A comparative study of efficacy and saftey of topical nonsteriodal anti-inflammatory eye drops in immediate post cataract surgery at a tertiary care hospital.

Dr Saiyadali Allisabanavar1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2017年1月27日最近更新:

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
80
试验地点
1
主要终点
1.Measuring percentage reduction in pain and is assessed by Visual analogue scale and Anterior Chamber Cells and flare by The Sun Working Group Grading Scheme .

研究概览

简要总结

This study is a randomized, double blind, parallel group trail comparing the safety and efficacy of topical Flurbiprofen 0.03% eye drops thrice daily  and topical Nepafenac 0.1%,  eye drops thrice daily for one week in 80 patients with uncomplicated cataract undergoing phacoemulsification/small incision cataract surgery fulfilling the inclusion/exclusion criteria that will be conducted in one center in India. The primary outcome measures will be Measuring percentage reduction in pain  and is  assessed by Visual analogue scale  and  Anterior Chamber Cells and flare after by Sun Working Group Grading  Scheme for  one week. The secondary outcomes will be Conjunctival redness by conjunctival hyperemia score and  lid edema by Lid edema scoring after one week.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Participant and Investigator Blinded

入排标准

年龄范围
18.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • 1.Patients willing to give written informed consent.
  • 2.Patients undergoing uncomplicated cataract surgery.

排除标准

  • 1.Surgeries other than phacoemulsification/small incisional cataract surgery.
  • 2.Known sensitivity to any of the ingredients in the study medications.
  • 3.Patients with preexisting ocular pathology, inflammation, tumor and glaucoma.
  • 4.History of previous intraocular surgery, uveitis and iritis or intraocular inflammation in the study eye.
  • 5.Use of steroids and Non steroidal inflammatory drugs by systemic route within the 14 days of surgery.

结局指标

主要结局

1.Measuring percentage reduction in pain and is assessed by Visual analogue scale and Anterior Chamber Cells and flare by The Sun Working Group Grading Scheme .

时间窗: one week

次要结局

  • Conjunctival redness by conjunctival hyperemia score and lid edema by Lid edema scoring(one week)

研究者

发起方
Dr Saiyadali Allisabanavar
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验